| 3.68 Data as of May 24 | +0.08 / +2.22%Today’s Change | 2.93 Today|||52-Week Range 9.20 | -52.52% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +63.04% increase from the last price of 3.68.

The current consensus among 6 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




